文档简介
1、 HYPERLINK https:/www.MedChemE/Targets/Nampt.html NAMPTNicotinamide phosphoribosyl transferase; PBEF; Visfatin; pre-B cell-enhancing factor; Pre-B cell colonyenhancing factorNicotinamide phosphoribosyltransferase (NAMPT) is the rate-limiting enzyme which catalyzes the conversion of nicotinamide(NAM)
2、 and phosphoribosyl-pyrophosphates to nicotinamide mononucleotide (NMN) in the mammalian nicotinamide adeninedinucleotide (NAD+) synthetic salvage pathway. NAMPT exists in two forms, intracellular NAMPT (iNAMPT) and extracellular NAMPT(eNAMPT).iNAMPT levels are high in brown adipose tissue (BAT), li
3、ver and kidney, intermediate in white adipose tissue (WAT), lung, spleen,testes and skeletal muscle, and undetectable in brain and pancreas. eNAMPT, thought to be produced through post-translationalmodification of iNAMPT, is released into plasma predominantly from adipose tissue, where it catalyses
4、the synthesis of NMN.Although intracellular NAMPT is a key enzyme in controlling NAD metabolism, eNAMPT has been reported to function as acytokine, with many roles in physiology and pathology. Circulating eNAMPT has been associated with several metabolic andinflammatory disorders, including cancer.w
5、ww.MedChemE 1 HYPERLINK https:/www.MedChemE/Targets/Nampt.html NAMPT HYPERLINK https:/www.MedChemE/Targets/Nampt.html HYPERLINK https:/www.MedChemE/Targets/Nampt.html Inhibitors HYPERLINK https:/www.MedChemE/FK866.html (E)-Daporinad(FK866; APO866) Cat. No.: HY-50876 HYPERLINK https:/www.MedChemE/CB-
6、300919.html CB HYPERLINK https:/www.MedChemE/CB-300919.html HYPERLINK https:/www.MedChemE/CB-300919.html 300919Cat. No.: HY-14375(E)-Daporinad (FK866) is an effective inhibitor ofnicotinamide phosphoribosyltransferase(NMPRTase; Nampt) with an IC of 0.09 nM.50CB 300919 is a quinazoline-based antitumo
7、ur agentwith high activity in the CH1 human ovarian tumourxenograft. CB 300919 has a continuous exposure (96h) growth inhibition IC value of 2 nM in human50CH1 ovarian tumor xenograft.Purity: 99.94%Clinical Data: Phase 2Size: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mgPurity: 98.53%Clinical Data: No Deve
8、lopment ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg HYPERLINK https:/www.MedChemE/CB30865.html CB30865(ZM 242421) Cat. No.: HY-14373 HYPERLINK https:/www.MedChemE/GMX1778.html CHS-828(GMX1778) Cat. No.: HY-10079CB30865 (ZM 242421) is a nicotinamidephosphoribosyltransferase (Nampt) inhibitor,with po
9、tent cytotoxicity. CB30865 is highly potentagainst a variety of human tumour cell lines (IC50values in the 1-10 nM range).CHS-828 (GMX1778) is a competitive inhibitor ofnicotinamide phosphoribosyltransferase(NAMPT), with an IC less than 25 nM. CHS-82850(GMX1778) exerts a cytotoxic effect by decreasi
10、ngthe cellular level of NAD+ and exhibits a potentanticancer activity.Purity: 98.05%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mgPurity: 99.35%Clinical Data: Phase 1Size: 10 mM 1 mL, 5 mg, 10 mg, 50 mg HYPERLINK https:/www.MedChemE/GNE-617.html GNE-617 HYPERLINK
11、https:/www.MedChemE/GNE-617.html HYPERLINK https:/www.MedChemE/GNE-617-hydrochloride.html GNE-617 HYPERLINK https:/www.MedChemE/GNE-617-hydrochloride.html HYPERLINK https:/www.MedChemE/GNE-617-hydrochloride.html hydrochlorideCat. No.: HY-15766 Cat. No.: HY-15766AGNE-617 is a specific NAMPT inhibitor
12、 thatinhibits the biochemical activity of NAMPT with anIC of 5 nM and exhibits efficacy in xenograft50models of cancer.GNE-617 hydrochloride is a specific NAMPTinhibitor that inhibits the biochemical activityof NAMPT with an IC of 5 nM and exhibits50efficacy in xenograft models of cancer.Purity: 99.
13、85%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 2 mg, 5 mg, 10 mg, 50 mg, 100 mgPurity: 99.28%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 2 mg, 5 mg, 10 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/gne-618.html GNE-618 HYPERLINK https:/www.MedChemE/gne-618.html HYPERLINK ht
14、tps:/www.MedChemE/gpp78.html GPP78Cat. No.: HY-12628(CAY10618) Cat. No.: HY-14374GNE-618 is a potent, orally active nicotinamidephosphoribosyl transferase (NAMPT) inhibitorwith an IC of 6 nM. GNE-618 depletes NAD levels50and induces tumor cell death. Anti-tumor activity.GPP78 (CAY10618) is a potent
15、Nampt inhibitorwith an IC of 3.0 nM for50 nicotinamide adeninedinucleotide (NAD) depletion. GPP78 is cytotoxic toneuroblastoma cell line SH-SY5Y cells with an IC50of 3.8 nM by inducing autophagy. GPP78 hasanti-cancer and anti-inflammatory effects.Purity: 98.14%Clinical Data: No Development ReportedS
16、ize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 250 mgPurity: 99.0%Clinical Data: No Development ReportedSize: 5 mg (11.38 mM * 1 mL in Methanol), HYPERLINK https:/www.MedChemE/lb-60-of61.html LB-60-OF61 HYPERLINK https:/www.MedChemE/lb-60-of61.html HYPERLINK https:/www.MedChemE/lb-60-of61-hydro
17、chloride.html LB-60-OF61 HYPERLINK https:/www.MedChemE/lb-60-of61-hydrochloride.html HYPERLINK https:/www.MedChemE/lb-60-of61-hydrochloride.html hydrochlorideCat. No.: HY-101280 Cat. No.: HY-101280ALB-60-OF61 is a NAMPT inhibitor and is acytotoxic compound with a selectivity towards MYCoverexpressin
18、g cell lines.LB-60-OF61 hydrochloride is a potent NAMPT(nicotinamide phosphoribosyltransferase)inhibitor. LB-60-OF61 hydrochloride is a cytotoxiccompound with a selectivity towards MYCoverexpressing cell lines.Purity: 99.25%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 m
19、gPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg2 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChemE/NAMPT_inhibitor-linker_2.html NAMPT HYPERLINK https:/www.MedChemE/NAMPT_inhibitor-linker_2.html HYPERLINK https:/www.MedChemE/NAMPT_inhibitor-lin
20、ker_2.html inhibitor-linker HYPERLINK https:/www.MedChemE/NAMPT_inhibitor-linker_2.html HYPERLINK https:/www.MedChemE/NAMPT_inhibitor-linker_2.html 2Cat. No.: HY-112616 HYPERLINK https:/www.MedChemE/Nampt-IN-1.html Nampt-IN-1(LSN3154567) Cat. No.: HY-12971NAMPT inhibitor-linker 2 is a drug-linkercon
21、jugates for ADC, composed of an NAMPTinhibitor as a payload, and a linker.Nampt-IN-1 (LSN3154567) is a potent and selectiveNAMPT inhibitor. Nampt-IN-1 inhibits purifiedNAMPT with an IC of 3.1 nM.50Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 99.48%Clinical Data: No Develo
22、pment ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg HYPERLINK https:/www.MedChemE/nampt-in-3.html Nampt-IN-3 HYPERLINK https:/www.MedChemE/nampt-in-3.html HYPERLINK https:/www.MedChemE/nampt-in-5.html Nampt-IN-5Cat. No.: HY-108701 Cat. No.: HY-130606Nampt-IN-3 (Compound 35) simultaneously inhi
23、bitnicotinamide phosphoribosyltransferase (NAMPT)and HDAC with IC s of 31 nM and 55 nM,50respectively. Nampt-IN-3 effectively induces cellapoptosis and autophagy and ultimately leads tocell death.Nampt-IN-5 is a potent nicotinamidephosphoribosyltransferase (NAMPT) inhibitor.Nampt-IN-5 also inhibits
24、CYP3A4 activity and hascellular IC s of 0.7 nM and 3.9 nM against A278050and COR-L23, respectively.Purity: 99.27%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 99.21%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 1
25、00 mg HYPERLINK https:/www.MedChemE/ot-82.html OT-82 HYPERLINK https:/www.MedChemE/ot-82.html HYPERLINK https:/www.MedChemE/sbi-797812.html SBI-797812Cat. No.: HY-136241 Cat. No.: HY-126255OT-82 is a potent, selective and orally activeinhibitor of NAMPT. OT-82 is selectively toxicto cells of hematop
26、oietic origin and inducescell death in a NAD+ dependent manner. OT-82 is apromising antineoplastic agent for the study ofhematological malignancies.SBI-797812 is structurally similar to active-sitedirected NAMPT inhibitors and blocks binding ofthese inhibitors to NAMPT with EC of 0.37 M.50Purity: 99.84%Clinical Data: Phase 1Size: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mgPurity: 98.85%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 1
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2024正规民间借款合同模板风险控制详述3篇
- 虚拟现实与增强现实技术合作合同
- 2024版房屋租赁合同(简化版)
- 2024年高标准土方运输及垃圾处理合同3篇
- 2025年度木托板绿色认证与市场推广合同3篇
- 2024权代理合同-商标注册与维权服务2篇
- 2024招投标与合同管理在文化旅游产业中的创新应用3篇
- 二零二五年度房产抵押担保合同解析与应用3篇
- 质数合数课程设计思路
- 知识产权顾问课程设计
- 滞销风险管理制度内容
- 关于物业服务意识的培训
- JJF 2184-2025电子计价秤型式评价大纲(试行)
- 排污许可证办理合同1(2025年)
- GB/T 44890-2024行政许可工作规范
- 上海科目一考试题库参考资料1500题-上海市地方题库-0
- 【7地XJ期末】安徽省宣城市宁国市2023-2024学年七年级上学期期末考试地理试题(含解析)
- 设备操作、保养和维修规定(4篇)
- 2025年度日历台历黄历模板
- 医疗行业十四五规划
- (完整版)四年级上册数学竖式计算题100题直接打印版
评论
0/150
提交评论